Cell cross talk within the lymphoma tumor microenvironment: follicular lymphoma as a paradigm
Blood,
Journal Year:
2023,
Volume and Issue:
143(12), P. 1080 - 1090
Published: Dec. 14, 2023
Language: Английский
Perspective on Immunoglobulin N-Glycosylation Status in Follicular Lymphoma: Uncovering BCR-Dependent and Independent Mechanisms Driving Subclonal Evolution
Gloria Pokuaa Manu,
No information about this author
Mariette Odabashian,
No information about this author
Sergey Krysov
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(7), P. 1219 - 1219
Published: April 4, 2025
Follicular
lymphoma
(FL)
is
a
heterogeneous
and
incurable
disease.
One
of
the
hallmark
features
FL
cells
introduction
N-glycosylation
(N-gly)
amino
acid
sequence
motifs
into
immunoglobulin
variable
(IgV)
region
through
ongoing
somatic
hypermutation
(SHM)
in
early
stages
development.
These
N-gly
motifs,
containing
oligomannoses,
are
rarely
found
healthy
B
but
evidently
play
crucial
role
clonal
evolution
survival
hostile
environment
germinal
centers.
The
random
nature
SHM
occasionally
results
loss
productive
(Ig)
genes
or
elimination
genes.
Such
events
typically
lead
to
deletion,
as
demonstrated
by
longitudinal
analysis
samples.
However,
rare
N-gly-negative
subclones
demonstrate
prolonged
with
evidence
SHM,
giving
rise
new
before
eventual
deletion.
This
observation
suggests
presence
specific
mechanisms
supporting
their
proliferation.
perspective
examines
current
literature
explores
whether
detailed
transcriptomic
functional
comparison
characterized
different
statuses,
particular
focus
on
subclones,
will
comprehensive
understanding
both
N-gly-dependent
independent
pro-survival
proliferative
transcriptional
signatures.
Specifically,
it
aims
deepen
our
pathobiology
identify
novel
therapeutic
targets
for
better
disease
management.
Language: Английский
B cell receptor silencing reveals the origin of high-grade B cell lymphomas with MYC and BCL2 rearrangements
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 17, 2024
Abstract
The
B
cell
receptor
(BCR)
is
essential
for
mature
lymphomas,
serving
as
therapeutic
target.
Here,
we
show
that
high-grade
lymphomas
with
MYC
and
BCL2
rearrangements
(HGBCL-DH-
)
predominantly
exhibit
immunoglobulin
heavy
(IGH)
chain
silencing,
leading
to
BCR
shutdown.
HGBCL-DH-
undetectable
IGH
(IGH
UND
differ
from
IGH-expressing
counterparts
germinal
center-zone
gene
programs,
expression
T
infiltration.
While
+
prefer
IGM/IG-Kappa
expression,
have
completed
class-switching,
favoring
IG-Lambda
(IGL)
light
chains.
preserve
IGHV
integrity,
overcoming
antigen-driven
selection.
silencing
precedes
onset
shapes
evolution
of
Follicular
Lymphoma
(FL)
or
FL/HGBCL-DH-
common
precursor.
In
pairs
models,
promoted
RAG1/2-dependent
IG
editing,
causing
t(8;22)(q24;q11)/
IGL
::
.
protected
models
killing
by
CD79B-targeting
Polatuzumab-Vedotin.
Collectively,
primarily
originate
BCR-silenced
isotype-switched
t(14;18)/
IGH::BCL2
-positive
(pre)FL
cells
acquiring
I
GL::MYC
translocations
during
revision,
clinical
implications.
Significance
These
findings
link
in
t(14;18)
(or
their
precursors)
RAG1/2
re-expression,
promoting
IGL::MYC
responsible
transformation
into
(HGBCL).
Predominant
the
complex
HGBCL
protects
tumor
CD79B-directed
Polatuzumab-Vedotin
killing.
Language: Английский
IgSeqR: a protocol for the identification, assembly, and characterization of full-length tumor Immunoglobulin transcripts from unselected RNA sequencing data
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 4, 2024
Abstract
Immunoglobulin
(IG)
gene
analysis
provides
fundamental
insight
into
B-cell
receptor
structure
and
function.
In
tumors,
it
can
inform
the
cell
of
origin
clinical
outcomes.
Its
value
has
been
established
in
two
types
chronic
lymphocytic
leukemia
with
unmutated
or
mutated
IGHV
genes
is
emerging
other
tumors.
The
traditional
PCR-based
techniques,
which
are
labor-intensive,
rely
on
attainment
either
a
dominant
sequence
small
number
subclonal
sequences
do
not
allow
automated
matching
clonal
phenotypic
features.
Extraction
expressed
tumor
IG
transcripts
using
high-throughput
RNA
sequencing
(RNA-seq)
be
faster
collection
multiple
matched
transcriptome
profile.
Analytical
tools
regularly
sought
to
increase
accuracy,
depth,
speed
acquisition
full
IGV-(IGD)-IGJ-IGC
combine
characteristics
RNA-seq
data.
We
provide
here
user-friendly
protocol
for
rapid
extraction,
identification,
accurate
determination
(leader
constant
region)
templated
non-templated
transcript
from
RNA-seq.
derived
amino
acid
interrogated
their
physico-chemical
and,
certain
lymphomas,
predict
glycan
occupying
acquired
N-glycosylation
sites.
These
features
will
then
available
association
studies
transcriptome.
resulting
information
also
help
refine
diagnosis,
prognosis,
potential
therapeutic
targeting
most
common
lymphomas.
Language: Английский
Antibodies disrupt bacterial adhesion by ligand mimicry and allosteric interference
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 12, 2024
Abstract
A
critical
step
in
infections
is
the
attachment
of
many
microorganisms
to
host
cells
using
lectins
that
bind
surface
glycans,
making
promising
antimicrobial
targets.
Upon
binding
mannosylated
FimH,
most
studied
lectin
adhesin
type
1
fimbriae
E.
coli
,
undergoes
an
allosteric
transition
from
inactive
active
conformation
can
act
as
a
catch-bond.
Monoclonal
antibodies
alter
FimH
glycan
various
ways
are
available,
but
mechanisms
these
remain
unclear.
Here,
we
use
cryoEM,
mass
spectrometry,
assays,
and
molecular
dynamics
simulations
determine
structure-function
relationships
underlying
antibody-FimH
binding.
Our
study
reveals
four
distinct
antibody
action:
ligand
mimicry
by
N-linked,
high-mannose
glycan;
stabilization
pocket
state;
conformational
trapping
states;
locking
through
long-range
effects.
These
structures
reveal
multiple
responses
protein
provide
blueprints
for
new
target
adhesins.
Language: Английский